Dionaldo, Arfel C.

HRN: 28-23-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
CEFTRIAXONE 1G (VIAL)
12/09/2025
12/16/2025
IV
2g
OD
T/C TBI
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: